| Global Market for Contract Research Organization (CRO) Services (PHM186C) |
|
Portfolio management & asset valuation |
|
Its comprehensive knowledge in clinical, regulatory, and market access strategy that helps optimize portfolio’s potential, making risk and reward decisions earlier and with greater knowledge. This segment services includes –
Building patient insights into assets, profile, and claims,
Portfolio optimization,
Asset valuation & indication prioritization,
Early evidence reviews,
Model-based drug development,
Integrated development strategy and planning.
|
|
Early development and innovation |
|
Its innovative strategies help navigate early-stage development complexities, enabling quicker decision-making and solid foundation for later work. We assist with biomarker selection, safety, supplies, logistics, and regulatory strategy. Services includes –
Phase I clinical trials,
Proof of concept: Phase Ib-IIa,
Patient engagement strategy and enrollment solutions,
Site Alliance Network and KOL engagement,
Protocol optimization,
Regulatory strategy,
Market access strategy and delivery,
Biomarker and genomic medicine strategy,
Clinical trial supply and logistics,
Patient inclusion,
Medical communications.
|
|
Integrated clinical development |
|
Its whole-study solutions prioritize patient safety, data integrity, regulatory compliance, and scientific rigor, minimizing risks, reducing workloads, and working within budget and schedule constraints. Services includes –
Phase IIb-IV clinical trials,
Real-world evidence,
Patient engagement strategy and enrollment solutions,
Protocol-driven, customized site solution strategy,
Regulatory approval, compliance, and outsourcing,
Market access strategy and delivery,
Clinical development technology optimization,
Clinical trial supply and logistics,
Patient inclusion,
Medical communications.
|
|
